Anti-Human IL12B Recombinant Antibody(Briakinumab)

Product Information

Catalog Number	YR1099
Product Name	Anti-Human IL12B Recombinant Antibody(Briakinumab)
Molecular Name	Briakinumab
Alias	Anti-IL12B Recombinant Antibody, Research Grade Briakinumab
CAS Number	339308-60-0
Molecular Weight	146.5 kDa
Target	IL12B[Homo sapiens]
Isotype	IgG1 Lambda
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	FCM, IP, ELISA, Neut, FuncS
Buffer	PBS, pH7.5
Background	Briakinumab (ABT-874) is a human monoclonal antibody being developed by Abbott Laboratories for the treatment of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis. As of 2011 drug development for psoriasis has been discontinued in the U.S. and Europe.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price